Your browser doesn't support javascript.
loading
4-Methylumbelliferone improves the thermogenic capacity of brown adipose tissue.
Grandoch, Maria; Flögel, Ulrich; Virtue, Sam; Maier, Julia K; Jelenik, Tomas; Kohlmorgen, Christina; Feldmann, Kathrin; Ostendorf, Yanina; Castañeda, Tamara R; Zhou, Zhou; Yamaguchi, Yu; Nascimento, Emmani B M; Sunkari, Vivekananda G; Goy, Christine; Kinzig, Martina; Sörgel, Fritz; Bollyky, Paul L; Schrauwen, Patrick; Al-Hasani, Hadi; Roden, Michael; Keipert, Susanne; Vidal-Puig, Antonio; Jastroch, Martin; Haendeler, Judith; Fischer, Jens W.
Afiliação
  • Grandoch M; Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Flögel U; Experimental Cardiovascular Imaging, Molecular Cardiology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Virtue S; MRC Metabolic Diseases Unit, Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom.
  • Maier JK; Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Jelenik T; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Kohlmorgen C; German Center for Diabetes Research (DZD e.V.), München-Neuherberg, Germany.
  • Feldmann K; Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Ostendorf Y; Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Castañeda TR; Institute of Pharmacology and Clinical Pharmacology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Zhou Z; German Center for Diabetes Research (DZD e.V.), München-Neuherberg, Germany.
  • Yamaguchi Y; Institute for Clinical Biochemistry and Pathobiochemistry, Medical Faculty, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Nascimento EBM; German Center for Diabetes Research (DZD e.V.), München-Neuherberg, Germany.
  • Sunkari VG; Institute for Clinical Biochemistry and Pathobiochemistry, Medical Faculty, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Goy C; Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Kinzig M; Department of Nutrition and Movement Sciences, Maastricht Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, The Netherlands.
  • Sörgel F; Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Bollyky PL; Institute for Clinical Chemistry, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Schrauwen P; Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany.
  • Al-Hasani H; Institute for Biomedical and Pharmaceutical Research, Nürnberg-Heroldsberg, Germany.
  • Roden M; Division of Infectious Diseases and Geographic Medicine, Dept. of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Keipert S; Department of Nutrition and Movement Sciences, Maastricht Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, The Netherlands.
  • Vidal-Puig A; German Center for Diabetes Research (DZD e.V.), München-Neuherberg, Germany.
  • Jastroch M; Institute for Clinical Biochemistry and Pathobiochemistry, Medical Faculty, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Haendeler J; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Fischer JW; German Center for Diabetes Research (DZD e.V.), München-Neuherberg, Germany.
Nat Metab ; 1(5): 546-559, 2019 05.
Article em En | MEDLINE | ID: mdl-31602424
ABSTRACT
Therapeutic increase of brown adipose tissue (BAT) thermogenesis is of great interest as BAT activation counteracts obesity and insulin resistance. Hyaluronan (HA) is a glycosaminoglycan, found in the extracellular matrix, which is synthesized by HA synthases (Has1/Has2/Has3) from sugar precursors and accumulates in diabetic conditions. Its synthesis can be inhibited by the small molecule 4-methylumbelliferone (4-MU). Here, we show that the inhibition of HA-synthesis by 4-MU or genetic deletion of Has2/Has3 improves BAT`s thermogenic capacity, reduces body weight gain, and improves glucose homeostasis independently from adrenergic stimulation in mice on diabetogenic diet, as shown by a magnetic resonance T2 mapping approach. Inhibition of HA synthesis increases glycolysis, BAT respiration and uncoupling protein 1 expression. In addition, we show that 4-MU increases BAT capacity without inducing chronic stimulation and propose that 4-MU, a clinically approved prescription-free drug, could be repurposed to treat obesity and diabetes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tecido Adiposo Marrom / Himecromona / Termogênese Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tecido Adiposo Marrom / Himecromona / Termogênese Limite: Animals Idioma: En Revista: Nat Metab Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha